Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Cephalalgia : an International Journal of Headache|April 16, 2019
Cyclic vomiting syndrome and benign paroxysmal torticollis are associated with a high risk of developing primary headache: A longitudinal studyRomina Moavero, Laura Papetti, Maria Chiara Bernucci, et al.The Journal of Biological Chemistry|January 8, 2008
Down-regulation of RNA editing in pediatric astrocytomas: ADAR2 editing activity inhibits cell migration and proliferationCaterina Cenci, Rita Barzotti, Federica Galeano, et al.Seminars in Thrombosis and Hemostasis|June 9, 2016
Thrombosis in Autoimmune Diseases: A Role for Immunosuppressive Treatments?Elena Silvestri, Antonella Scalera, Giacomo Emmi, et al.Seminars in Thrombosis and Hemostasis|March 17, 2012
The thrombophilic pattern of different clinical manifestations of venous thromboembolism: a survey of 443 cases of venous thromboembolismElisa Grifoni, Rossella Marcucci, Gabriele Ciuti, et al.Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|January 9, 2014
Staphylococcus aureus infections and factors associated with resistance to methicillin in a hospital emergency departmentJuan González-Castillo, Caterina Cenci, Esther Rodriguez-Adrada, et al.Atherosclerosis|July 18, 2012
A hypercoagulable and hypofibrinolytic state is detectable by global methods in patients with retinal vein occlusionAnna Paola Cellai, Donatella Lami, Sandra Fedi, et al.Thrombosis Research|July 31, 2014
Residual perfusion defects in patients with pulmonary embolism are related to impaired fibrinolytic capacityDonatella Lami, Anna Paola Cellai, Emilia Antonucci, et al.Journal of Thrombosis and Thrombolysis|August 22, 2013
Hyperhomocysteinemia in patients with pulmonary embolism is associated with impaired plasma fibrinolytic capacityAnna Paola Cellai, Donatella Lami, Emilia Antonucci, et al.Blood|July 14, 2018
Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndromeVittorio Pengo, Gentian Denas, Giacomo Zoppellaro, et al.Pageof 2